Emmanuelle Godefroy

Title: Emmanuelle Godefroy: Innovator in Medical Research

Introduction

Emmanuelle Godefroy is a notable inventor based in Nantes, France. She has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of diseases related to T lymphocytes. With a total of 2 patents, her work has the potential to impact the lives of many patients suffering from inflammatory bowel diseases.

Latest Patents

One of her latest patents focuses on the diagnosis, prognosis, and treatment of diseases associated with a decrease in specific T lymphocyte populations. This invention involves a method for determining the number, concentration, and proportion of T lymphocytes with a CD4CD8αα phenotype, which express CCR6 and/or CXCR6. This method is crucial for diagnosing and predicting the risk of developing inflammatory bowel diseases, such as Crohn's disease. The second patent involves peptides derived from the MMP-2 metalloproteinase, which form T cell epitopes when presented by MHC Class I molecules. These peptides are utilized in anti-tumor therapy, showcasing her innovative approach to immunotherapy.

Career Highlights

Emmanuelle Godefroy has worked with esteemed institutions such as Université de Nantes and the Institut National de la Santé et de la Recherche Médicale. Her research has been pivotal in advancing our understanding of immune responses and their implications for various diseases.

Collaborations

Throughout her career, Godefroy has collaborated with notable colleagues, including Francine Jotereau and Yannick Guilloux. These partnerships have enriched her research and contributed to her success as an inventor.

Conclusion

Emmanuelle Godefroy's innovative work in medical research highlights her commitment to improving patient outcomes through advanced diagnostic and therapeutic methods. Her contributions are invaluable in the ongoing fight against diseases like inflammatory bowel disease and cancer.